Safety, Tolerability, and Biologic Outcomes of Semaglutide and Tirzepatide for Obesity: A Systematic Scoping Review of Adverse Events, Biomarkers, Inflammation, and Evidence Gaps
Pages: 10-14 Author: Fouzylesloom, Associ. Prof. Dr. Norshafarina Shari